|
Market Closed -
Euronext Paris
11:55:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.7000 EUR | -1.96% |
|
-7.89% | -27.08% |
| 09-25 | Transgene provides update on its operations |  |
| 09-08 | Transgene Expands ProBioGen Partnership With Additional License | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 216M | - | ||||
| 74.16B | |||||
| 57.39B | |||||
| 47.64B | |||||
| 44.29B | - | - | - | - | - |
| 42.5B |
- Stock Market
- Stocks
- TNG Stock
- Charts Transgene
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
